← Open Payments lookup

PAUL MILLER: Open Payments

NPI 1447561998 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,194 in 56 payments from 8 companies in 2025. Trend: 2023 $925 · 2024 $1,457 · 2025 $2,194

Food & beverage: $2,194
CompanyPaymentsAmount
ABBVIE INC.32$969
Neurocrine BioSciences, Inc.5$304
Alkermes, Inc.3$256
Axsome Therapeutics, Inc.2$242
E.R. Squibb & Sons, L.L.C.11$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$127
Vanda Pharmaceuticals Inc.1$125
Biogen, Inc.1$24

Products named: VRAYLAR, INGREZZA, Auvelity, COBENFY, ARISTADA, CAPLYTA, FANAPT, LYBALVI.

Industry payments across NY — which companies pay providers there.